A 38-year-old man from Mumbai with a 10-year history of smoking (20 cigarettes/day) presents with hemoptysis and is diagnosed with lung cancer. An epidemiologist is planning a study to quantify the association between smoking intensity (cigarettes per day) and lung cancer risk. The researcher plans to recruit 300 lung cancer patients from three major hospitals and 300 age-matched controls without lung cancer from the general population, then ask both groups detailed questions about their smoking history over the past 20 years. What is the primary advantage of this case-control design over a prospective cohort study for this research question?

Explanation

## Case-Control Study Advantages in Lung Cancer Epidemiology ### Why Case-Control Excels Here **Key Point:** Case-control studies are *efficient* for studying diseases with long latency periods (like lung cancer, which may take 10–20 years to develop after smoking initiation). A prospective cohort would require following thousands of smokers for decades. **High-Yield:** The primary advantage of case-control over prospective cohort is: - **Speed:** Results in months/years vs. 10–20 years - **Cost:** Smaller sample, no follow-up infrastructure - **Feasibility:** Practical for rare or late-onset diseases ### Efficiency Comparison: Case-Control vs. Prospective Cohort | Dimension | Case-Control | Prospective Cohort | |-----------|--------------|-------------------| | **Time to results** | 1–2 years | 10–20 years (lung cancer) | | **Sample size** | 300 cases + 300 controls = 600 | 10,000+ smokers followed | | **Cost** | ~₹50–100 lakh | ₹10+ crores | | **Personnel** | Interviewers, data managers | Field staff, clinicians, long-term follow-up | | **Attrition** | Minimal (cases identified) | High (loss to follow-up over decades) | | **Feasibility** | High | Low for long-latency diseases | ### Why Other Options Are Incorrect 1. **Higher RR and precision:** Case-control calculates *odds ratio* (OR), not relative risk (RR). OR approximates RR only when disease is rare. Cohort directly measures RR, which is more precise. 2. **Eliminates recall bias:** False. Case-control studies are *prone* to recall bias because exposure data is collected retrospectively. Patients with lung cancer may recall smoking history differently than controls. 3. **Direct incidence measurement:** Only cohort studies measure incidence directly. Case-control measures odds of exposure among cases vs. controls — it infers association, not incidence. **Clinical Pearl:** For occupational and environmental diseases with 10–20 year latency (asbestos-related lung cancer, byssinosis, silicosis), case-control is the only practical design. A prospective cohort would be obsolete before results were available. **Mnemonic:** **SPEED** — *Study design, Practical for long latency, Economical, Efficient sample, Disease already present* = Case-Control advantage.